Relationship between expression of HBV-infection markers in placenta and clinical data of mothers and their newborns
https://doi.org/10.22625/2072-6732-2021-13-2-95-101
Abstract
Vertical transmission of viral hepatitis B (HBV) is one of the main transmission ways in endemic regions. There is a relationship between structural changes in the placenta and the clinical course of HBV infection. The risk of vertical transmission of hepatitis B depends on the condition of the placenta.
The goal of this work was to study the relationship between HBsAg and / or HBcorAg expression in placenta on the one hand, and clinical parameters of mothers and newborns on the other hand.
The study included 19 patients with CHB who gave birth at the Botkins infectious disease hospital in 2019. The first group included patients with markers of HBV infection (HBsAg and / or HBcorAg) detectable via immunohistochemical examination in at least one of the layers of the placenta. In patients from the second group, no markers of HBV infection were detected in any layer of the placenta. Inflammatory changes in placenta were detected in all women from the first group and in 9 (64%) women from the second group. HBsAg in umbilical cord blood was detected in 3 (16%) newborns. In two patients, whose children had HBsAg in the umbilical cord blood, no markers of HBV infection were detected in placenta. In the first group, only one newborn had HBsAg in umbilical cord blood. In two patients receiving an antiviral treatment during pregnancy, markers of HBV infection were identified in the placenta. Markers of HBV infection in placenta were also detected in women with undetectable viral load.
Conclusions
- Markers of HBV infection can be found in placenta at low maternal viral load.
- HBsAg in umbilical cord blood can be detected even in patients with no markers of HBV infection in placenta.
- Antiviral treatment during pregnancy does not prevent the possibility of placenta’s infection with HBV.
About the Authors
M. A. Belopolskaya
Clinical Infectious Diseases Hospital named after S.P. Botkin;
Institute of Experimental Medicine
Russian Federation
Russian Federation
Saint-Petersburg
V. E. Karev
Pediatric Research and Clinical Center for Infection Diseases
Russian Federation
Russian Federation
Saint-Petersburg
V. Yu. Avrutin
Institute for Systems Theory
Germany
Germany
Stuttgart
A. V. Dmitriev
Institute of Experimental Medicine
Russian Federation
Russian Federation
Saint-Petersburg
D. A. Gusev
Clinical Infectious Diseases Hospital named after S.P. Botkin;
First Saint-Petersburg State Medical University named after аcademician I.P. Pavlov
Russian Federation
Russian Federation
Saint-Petersburg
References
1. Hepatitis B in pregnancy / G. Borgia, M. A. Carleo, G. B. Gaeta, I. Gentile // World J Gastroenterol. – 2012. – Vol. 18, № 34. – P. 4677-4683.
2. Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy / C. L. Thio, N. Guo, C. Xie [et al.] // Lancet Infect Dis. – 2015. – Vol. 15, № 8. – P. 981-985.
3. WHO-UNICEF estimates of HepB3 coverage / World Health Organization. URL: https://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragehepb3.html (дата обращения: 16.05.2020).
4. Tsinzerling V.A., Melnikova V.F. Perinatal Infections: Questions of pathogenesis, morphological diagnostics and clinic–pathological correlations. Practical Manual. SPb Elbi– SPb, 2002, 352 p (in Russian)
5. Connell L.E., Salihu H.M., Salemi J.L., et al. Maternal hepatitis B and hepatitis C carrierstatus and perinatal outcomes. Liver International. 2011; 31: 1163–1170. doi:10.1111/j.1478-3231.2011.02556.x
6. Randyuk Yu.O., Davidenko I.S. Influence of asymptomatic forms of HB viral infection on the morphological state of the placenta // Infectious Diseases. – 2004. – No. 2. – P. 17–20.
7. Yu M, Jiang Q, Gu X, et al. (2013) Correlation between Vertical Transmission of Hepatitis B Virus and the Expression of HBsAg in Ovarian Follicles and Placenta. PLoS ONE 8(1): e54246. https://doi.org/10.1371/journal.pone.0054246
8. Sirilert S, Khamrin P, Kumthip K,Malasao R, Maneekarn N, Tongsong T. Placental infection of hepatitis B virus among Thai pregnant women: Clinical risk factors and its association with fetal infection. Prenatal Diagnosis. 2020;40:380–386. https://doi.org/10.1002/pd.5628
9. Prevalence and virological features of occult hepatitis B virus infection in female sex workers who work uncontrolled in Turkey / B. Pinarbasi, D. Onel, F. Cosan [et al.] // Liver Int. – 2009. – Vol. 29. – P. 227-230.
10. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection / G. R. Han, M. K. Cao, W. Zhao [et al.] // J Hepatol. – 2011. – Vol. 55, № 6. – P. 1215-1221.
11. T.U. Pestrikova, N.A. Kosenko Characteristic of morphological changes in placenta in pregnant women with chronic viral hepatitis B and C. Far Eastern medical journal. 2012; 4: 59– 62.
Review
For citations:
Belopolskaya M.A., Karev V.E., Avrutin V.Yu., Dmitriev A.V., Gusev D.A. Relationship between expression of HBV-infection markers in placenta and clinical data of mothers and their newborns. Journal Infectology. 2021;13(2):95-101. (In Russ.) https://doi.org/10.22625/2072-6732-2021-13-2-95-101
Views:
601
.png)
.png)
Email this article 